ArticleScientific reports2019

A novel scaffold for EGFR inhibition: Introducing N-(3-(3-phenylureido)quinoxalin-6-yl) acrylamide derivatives.

Daniel Nascimento do Amaral et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.